Rallybio
RLYB
58 hedge funds and large institutions have $105M invested in Rallybio in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.69% less ownership
Funds ownership: 11.01% → 10.32% (-0.69%)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
2% less funds holding
Funds holding: 59 → 58 (-1)
44% less capital invested
Capital invested by funds: $188M → $105M (-$83.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$347K |
| 2 |
State Street
Boston,
Massachusetts
|
+$63.6K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$63.4K |
| 4 |
Squarepoint
New York
|
+$55.2K |
| 5 |
Capstone Investment Advisors
New York
|
+$54.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
-$1.07M |
| 2 |
CA
CHI Advisors
New York
|
-$823K |
| 3 |
CCM
CAAS Capital Management
New York
|
-$178K |
| 4 |
Goldman Sachs
New York
|
-$171K |
| 5 |
BlackRock
New York
|
-$122K |
RLYB Hedge Fund Activity: Q3 2023 in Review
58 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q3 2023, worth a combined $105M — down 44% from $188M a quarter earlier.
Fund positioning in RLYB was balanced in Q3 2023: 5 funds opened new positions, 5 closed out, 13 added to existing stakes and 14 trimmed.
The largest buyer was Bridgeway Capital Management, adding an estimated $347K. The largest seller was Mariner, cutting an estimated $1.07M.
- 58 institutional investors held Rallybio (RLYB) as of Q3 2023, down from 59 in Q2 2023.
- Funds reported $105M of Rallybio stock for Q3 2023, down 44% quarter-over-quarter.
- 5 funds opened new Rallybio positions in Q3 2023 and 5 closed out, a net change of 0 holders.
- The largest Rallybio buyer in Q3 2023 was Bridgeway Capital Management, an estimated $347K added.
- The largest Rallybio seller in Q3 2023 was Mariner, an estimated $1.07M sold.
Based on aggregated 13F filings for Q3 2023.